These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 769897)

  • 1. Immunodepressive serum treatment of acute heart transplant rejection.
    Coulson AS; Zeitman VH; Stinson EB; Griepp RB; Bieber CP; Dong E; Shumway NE
    Br Med J; 1976 Mar; 1(6012):749-50. PubMed ID: 769897
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Impella 5L for acute allograft rejection postcardiac transplant.
    Chandola R; Cusimano R; Osten M; Horlick E
    Thorac Cardiovasc Surg; 2012 Jun; 60(4):302-4. PubMed ID: 22547305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute humoral rejection in an infant without risk factors after heart transplantation.
    Binsalamah ZM; Marcano J; Zea-Vera R; Tunuguntla H; Kearney DL; Heinle JS; Fraser CD; Mery CM
    J Card Surg; 2018 Feb; 33(2):126-128. PubMed ID: 29399877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunomorphology and pathology of the allotransplanted heart (without immunodepressive effect)].
    Rapoport IaL; Fal'kovskiĭ GE; Galankina IE
    Arkh Patol; 1971; 33(4):43-9. PubMed ID: 4945787
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [50 Years ago: First Successful Treatment of Acute Allograft Rejection after a Human Heart Transplantation].
    Land WG
    Dtsch Med Wochenschr; 2018 Dec; 143(25):1864-1865. PubMed ID: 30562821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometry controlled induction therapy with ATG and noninvasive monitoring of rejection--a modern management concept after heart transplantation].
    Wagner FM; Tugtekin SM; Matschke K; Platzbecker U; Gulielmos V; Schüler S
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1566-7. PubMed ID: 9931945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection in pediatric heart transplantation.
    Fukushima N; Gundry SR; Razzouk AJ; Bailey LL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1423-5. PubMed ID: 8382868
    [No Abstract]   [Full Text] [Related]  

  • 9. The Impella 2.5 L for percutaneous mechanical circulatory support in severe humoral allograft rejection.
    Beyer AT; Hui PY; Hauesslein E
    J Invasive Cardiol; 2010 Mar; 22(3):E37-9. PubMed ID: 20197587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future challenges in therapy for antibody-mediated rejection.
    Nair N; Ball T; Uber PA; Mehra MR
    J Heart Lung Transplant; 2011 Jun; 30(6):612-7. PubMed ID: 21474341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with a monoclonal interleukin-2 receptor antibody (BT 563) for rejection therapy after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Freigassner M; Auer T; Kleinert R; Wasler A; Petutschnigg B; Müller H
    Transplant Proc; 1994 Dec; 26(6):3237-9. PubMed ID: 7998128
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OKT3 treatment of cardiac allograft rejection.
    Haverty TP; Sanders M; Sheahan M
    J Heart Lung Transplant; 1993; 12(4):591-8. PubMed ID: 8369321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graft rejection reaction and immunosuppression following heart transplantation].
    Leonardi L; Lüthy A; Mondada C; Waser M; Laske A; Turina M; Gallino A
    Ther Umsch; 1990 Feb; 47(2):147-51. PubMed ID: 2180104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance steroid use at 30 days post-transplant and outcomes of pediatric heart transplantation: A propensity matched analysis of the Pediatric Heart Transplant Study database.
    Auerbach SR; Kukreja M; Gilbert D; Bastardi H; Feingold B; Knecht K; Kaufman BD; Brown RN; Miyamoto SD
    J Heart Lung Transplant; 2015 Aug; 34(8):1066-72. PubMed ID: 25980572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
    Li CK; Shing MM; Chik KW; Lee V; Tsang KS; Yuen PM
    Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: a preliminary clinical and immunopathologic report.
    Costanzo-Nordin MR; McManus BM; Wilson JE; O'Sullivan EJ; Hubbell EA; Robinson JA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):881-3. PubMed ID: 8442255
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation.
    Shumway NE
    J Ark Med Soc; 1982 Dec; 79(7):221-7. PubMed ID: 6219091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.